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Summary
Type-1 ﬁmbriae are important virulence factors for
the establishment of Escherichia coli urinary tract
infections. Bacterial adhesion to the high-
mannosylated uroplakin Ia glycoprotein receptors of
bladder epithelium is mediated by the FimH adhesin.
Previous studies have attributed differences in
mannose-sensitive adhesion phenotypes between
faecal and uropathogenic E. coli to sequence varia-
tion in the FimH receptor-binding domain. We ﬁnd
that FimH variants from uropathogenic, faecal and
enterohaemorrhagic isolates express the same speci-
ﬁcities and affinities for high-mannose structures.
The only exceptions are FimHs from O157 strains that
carry a mutation (Asn135Lys) in the mannose-binding
pocket that abolishes all binding. A high-mannose
microarray shows that all substructures are bound
by FimH and that the largest oligomannose is not
necessarily the best binder. Affinity measurements
demonstrate a strong preference towards oligoman-
nosides exposing Mana1-3Man at their non-reducing
end. Binding is further enhanced by the b1-4-linkage
to GlcNAc, where binding is 100-fold better than that
of a-D-mannose. Mana1-3Manb1-4GlcNAc, a major oli-
gosaccharide present in the urine of a-mannosidosis
patients, thus constitutes a well-deﬁned FimH
epitope. Differences in affinities for high-mannose
structures are at least 10-fold larger than differences
in numbers of adherent bacteria between faecal and
uropathogenic strains. Our results imply that the car-
bohydrate expression proﬁle of targeted host tissues
and of natural inhibitors in urine, such as Tamm-
Horsfall protein, are stronger determinants of adhe-
sion than FimH variation.
Introduction
Urinary tract infections (UTI) occur frequently in humans
and are most prevalent in women, who stand an almost
50% chance to experience a UTI in their lifetime. Uro-
pathogenic Escherichia coli (UPEC) is the aetiologic
agent in about 80% of the reported cases.Acute UTIs can
be effectively treated with antibiotics, but chronic recur-
rence is a problem (Justice et al., 2004) as is the emer-
gence of antibiotic-resistant strains (Blahna et al., 2006).
Uropathogenic E. coli expresses a number of adhesins
for speciﬁc attachment to carbohydrate-containing recep-
tors on the epithelium of the urinary tract (Berglund and
Knight, 2003; Westerlund-Wikström and Korhonen,
2005). This diversity of adhesins allows UPEC to exploit
the differential expression of cell surface receptors in dis-
tinct parts of the urinary tract, thus generating different
clinical outcomes. For example, P-piliated UPEC causes
pyelonephritis by binding to galabiose-containing
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binding type-1 pili promote cystitis by targeting uroplakin
Ia (UPIa) on the mucosal surface of the urinary bladder.
Type-1 pili are important UPEC virulence factors
(Mulvey, 2002; Justice et al., 2004; Kau et al., 2005). They
consist of a cylindrical rod of repeating immunoglobulin-
like (Ig-like) FimAsubunits, followed by a short and stubby
tip ﬁbrillum. Pilus assembly occurs through the
chaperone/usher pathway. With the help of a ‘donor
strand exchange’ mechanism, the immunoglobulin fold of
each pilin becomes completed by the amino-terminal
extension from the next pilin deposited at the outer mem-
brane usher by the periplasmic chaperone (Zavialov et al.,
2003; Sauer et al., 2004). The FimH adhesin caps the
ﬁbrillum of type-1 pili, with a receptor-binding domain
(residues 1–158) joined to a pilin domain (residues 159–
279) that links the adhesin to FimG, which connects to the
rest of the pilus.
The FimH adhesin is responsible for mannose-sensitive
bacterial adhesion. The primary physiological receptor for
FimH in the urinary tract is UPIa (Zhou et al., 2001; Xie
et al., 2006), a high-mannose glycoprotein abundantly
present on the superﬁcial umbrella cells of the
uroepithelium. FimH can however, recognize a wide
range of glycoproteins carrying one or more N-linked
high-mannose structures. FimH can also bind yeast
mannans and mediate agglutination of yeast and red
blood cells. FimH-mediated binding can be inhibited by
D-mannose and a variety of natural and synthetic saccha-
rides containing terminal mannose residues (Firon et al.,
1983; 1984; Sharon et al., 1983; Neeser et al., 1986;
Rockendorf et al., 2002). This apparently broad binding
range is based on the structural requirement of FimH for
an a-linked mannose, either in free form or at the non-
reducing end of a glycan (Hung et al., 2002).
Despite the high conservation ( 98%) of ﬁmH alleles
from different E. coli isolates (Abraham et al., 1988; Hung
et al., 2002; Vandemaele et al., 2003), minor sequence
differences have been indicated to correlate with differen-
tial binding and adhesion phenotypes (Sokurenko et al.,
1994; 1995; 1997; 1998). Intriguingly, most of the variable
residues are located far away from the mannose-binding
pocket and are instead close to the linker region between
the receptor-binding domain and the pilin domain. The
mannose-binding pocket is highly conserved across all
known FimHs, except for an asparagine-to-lysine mutation
at position 135 in the FimH from genome sequenced
O157:H7 enterohaemorrhagic E. coli (EHEC). This muta-
tion has been predicted to abolish mannose binding (Hung
et al., 2002). O157:H7 is the best characterized EHEC
serotype and the causative agent of ‘hamburger disease’.
The ﬁne speciﬁcity of FimH had not been characterized
yet in molecular detail, despite considerable interest in
understanding the basis for FimH-mediated adhesion.
This interest originates from long-standing observations
that blocking the FimH–receptor interaction prevents bac-
terial infection (Aronson et al., 1979; Langermann et al.,
1997; Sharon, 2006). We investigated, in molecular detail,
the binding properties of FimH receptor-binding domains
from the E. coli laboratory strain K-12, the J96 and CI#4
UPEC strains, the intestinal isolate F-18 E. coli as well as
four EHEC strains. The ﬁne speciﬁcity of FimH for
high-mannose epitopes was probed using a series of
oligomannosides corresponding to substructures of high-
mannose N-linked glycans on proteins.
Results
Binding of uropathogenic FimH to a high-mannose
microarray
A high-mannose microarray (Adams et al., 2004; Ratner
et al., 2004) was employed to study the carbohydrate
binding speciﬁcity of FimH from UPEC strain J96. For this
purpose, a series of high-mannose oligosaccharides was
synthesized (Fig. S1) (Ratner et al., 2002), including
several substructures of the triantennary oligomannose 9
(Fig. 1). The synthetic oligosaccharides were linked onto
the array in the anomeric conﬁguration in which they
occur in N-linked high-mannose structures (Fig. S1), via a
thiol-terminated triethylene glycol linker that permits their
attachment onto maleimide-functionalized glass slides
through the formation of a stable covalent bond. A stan-
dard DNAarray printer was used to create a carbohydrate
microarray of 480 spots (15 replica per sample; Fig. S2).
The use of carbohydrate solutions with different concen-
trations, ranging from 2 mM to 0.25 mM, allowed the esti-
mation of the carbohydrate binding proﬁle for the
receptor-binding domain of FimHJ96, FimHrbJ96, by com-
paring the ﬂuorescence intensities of spots at subsaturat-
ing concentration levels. The results unambiguously
showed that FimHrbJ96 bound to all mannosides (Figs. 2
and S2) and, with the exception of D-mannose, gave rise
to similar ﬂuorescence signals. No signal was observed
for b-linked D-galactose, which served as the negative
control.
Binding of linear trimannosides to FimH from
uropathogenic and faecal E. coli strains
To investigate if allelic differences in ﬁmH cause differ-
ences in carbohydrate binding at the molecular level,
mannoside binding of the FimH receptor-binding domains
from a faecal F-18 (FimHrbF-18) and a uropathogenic CI#4
(FimHrbCI#4) E. coli isolate were compared with the previ-
ously characterized FimH receptor-binding domain from
the uropathogenic E. coli J96 strain (FimHrbJ96), using the
[3H] D-mannose displacement assay (Table 1) (Bouckaert
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isogenic strain expressing ﬁmHF-18 and ﬁmHCI#4, have pre-
viously been shown to mediate distinct adhesion patterns
(Sokurenko et al., 1995). FimHrbF-18 and FimHrbCI#4 differ
from FimHrbJ96 by substitutions Val27Ala, Asn70Ser and
Ser78Asn (Fig. 3A). In addition, FimHrbCI#4 has a
Gly73Glu substitution. None of these residues are located
close to the mannose-binding pocket (Fig. 3B). The equi-
librium dissociation constants of FimHrbJ96, FimHrbF18 and
FimHrbCI#4 for ﬁve trimannosides, which correspond to
linear substructures of high-mannose glycans (Fig. 1), are
in the range of 0.35–7.5 mM (Table 1). Remarkably, a
similar binding proﬁle is observed for all three FimH vari-
ants (Fig. 4).
Docking of linear trimannosides to FimH
AutoDock3 was used to carry out docking studies to the
FimHJ96 mannose-binding site for six linear trisaccharides
that correspond to substructures of high-mannose:
the trimannosides from Table 1 and Mana1-3Manb1-
4GlcNAc. Docking produced one predominant binding
mode, whereby the mannose residue at the non-reducing
end is inserted in the mannose-binding pocket in the
same way as experimentally observed for D-mannose in
the FimH-mannose crystal structure (Bouckaert et al.,
2005). The best docked energy is predicted for Mana1-
3Manb1-4GlcNAc (Fig. 5). Its middle mannose residue as
well as the N-acetylglucosamine residue at the reducing
Fig. 1. Structure of the largest high-mannose glycan, oligomannose 9, indicating the D1, D2 and D3 arms.
Fig. 2. Fluorescence signal observed for high-mannose microarray binding by FimHrbJ96 at 0.5 mM. The immobilized oligosaccharides are
linked at their reducing end to a thiol-terminated triethylene glycol (insert). Compounds 1–3 are oligomannose 9, 6 and 3, respectively, minus
the chitobiose (GlcNAc)2 (Fig. S1), b-linked like in high-mannose structures (Fig. 1). Mana1-2Mana1-2Man (4), Mana1-2Mana1-6Mana1-6Man
(5), D-mannose (6) and Mana1-6Mana1-6Man (7) are all a-linked on the array (Fig. S1), as in natural high-mannose (Fig. 1). D-galactose (8) is
b-linked (Fig. S1). Numbers above the bars are DG values (kcal mole
-1), calculated from the affinities measured by SPR (Table 2) for identical
(4, 6 and 7) or similar (1–3) compounds. nb, no binding; nd, not determined.
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shaped by Ile52, Tyr48 and Tyr137. Also Thr51 interacts,
previously shown to hydrogen bond with the carbonyl
group on methyl umbelliferyl mannose (Bouckaert et al.,
2005).
FimH variation in enterohaemorrhagic E. coli strains
To obtain an overview of the range of variation in FimH
from EHEC strains, FimH from 22 EHEC isolates were
sequenced (Fig. S3). A selection was made from the 22
new sequences of EHEC FimH, which best reﬂects the
observed spectrum of variations in FimH, in an effort to
assess the contributions of multiple, concurrent variant
residues in the FimH receptor-binding domain to differ-
ences in FimH affinity and to bacterial adhesion. FimH
receptor-binding domains from four EHEC variants were
produced and used for binding studies (Table 2).
FimHrbK514, originating from E. coli strain K514 and with
the same sequence as the UPEC FimHrbJ96, was used as
Table 1. Binding of linear trimannosides to FimH from three different
E. coli strains.
Ligand
Kd (nM) (at 37°C)
J96 CI#4 F-18
D-mannose 4100 10 700 9800
Mana1-2Mana1-2ManaOMe 1600 3 950 3250
Mana1-2Mana1-3ManaOMe 1800 3 650 3050
Mana1-2Mana1-6ManaOMe 830 2 200 1800
Mana1-3Mana1-6ManaOMe 350 1 030 730
Mana1-6Mana1-6ManaOMe 1400 7 500 5900
Affinity measurements via the displacement of [
3H] D-mannose. The
trimannosides correspond to the branches of the high-mannose tree
(Fig. 1) and are methylated at their reducing end.
Fig. 3. Sequence (A) and location (B) of the
variations (raspberry red) in the FimH
receptor-binding domains of studied E. coli
strains. A bound butyl a-D-mannoside (red
ball-and-stick model) indicates the location of
the binding site (Bouckaert et al., 2005).
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O2:K1:H6, whereas FimHEH485, FimHEH349 and FimHEH297
originate from O157:H7 E. coli strains. The FimH
sequence variation in EHEC involves largely the same
residues as in faecal and uropathogenic E. coli (Fig. 3A),
except for the Asn135Lys mutation. FimHrbEH485 differs
from FimHrbJ96 or FimHK514 at residue 27 only, which is an
alanine as in all 22 sequenced EHEC FimH proteins.
FimHrbEH297 in addition has the Asn135Lys change that
has been predicted to abolish mannose binding (Hung
et al., 2002), whereas FimHrbEH349 has Phe instead of Leu
at position 144, which is located directly underneath the
mannose-binding pocket. FimHrbEH12 has the Asn70Ser
and Ser78Asn substitutions, typical for ﬁmH alleles from
faecal E. coli isolates, as well as two rare substitutions
(Asp37His and Gly66Asp) (Fig. 3). Because its sequence
is the most different and has some of the common faecal
alleles, FimHrbEH12 was most frequently selected for
extensive comparison of oligomannoside affinities with
FimHrbK514 (Table 2).
Oligomannoside binding to FimH reveals
strain-independent binding proﬁles
The solution equilibrium binding constants of FimH for
most natural oligomannoside substructures, present in
the glycan part of high-mannose glycoproteins (Fig. 1),
were characterized in an surface plasmon resonance
Fig. 4. Comparison of the binding proﬁles of
FimH variants with high-mannose
substructures. The Gibbs free energy of
binding was calculated from the measured
affinities of FimHrbJ96, FimHrbF-18 and
FimHrbCI#4 for the trimannosides used for
displacement of [
3H] D-mannose (Table 1),
and of FimHrbEH485, FimHrbEH12 and FimHrbK514
for the oligomannosides used in the SPR
assay (Table 2). The x-axis displays their
common mannoside moieties.
Fig. 5. Predicted (AutoDock3) mode of binding of
Mana1-3Manb1-4GlcNAc (ball-and-stick representation) to FimH
(PDB entry code 1TR7) [molecular surface presentation using
GRASS (Nayal et al., 1999)]. The ﬁgure illustrates how the
non-reducing mannose is buried in the cavity and the middle
mannose and GlcNAc at the reducing end insert in the tyrosine
gate between Tyr48 and Tyr137.
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essentially the same glycan affinities for FimHrbK514 and
the FimH receptor-binding domains from EHEC strains
(Table 2, Fig. 4). Two of the linear trimannosides used in
the [3H] D-mannose displacement experiments (Table 1),
modiﬁed to have triethylene glycol instead of a methyl
group at their reducing end, were also included in the SPR
measurements (Table 2).As shown previously (Bouckaert
et al., 2005), there is a good agreement in binding con-
stants obtained using either of the two techniques (SPR or
[3H] D-mannose displacement). Most importantly, we
observe nearly the same affinities among UPEC and
EHEC FimH and alike binding proﬁles for all studied FimH
variants (Fig. 4).
Table 2. Kd as measured by surface plasmon resonance.
Mannose and linear mannosides (Compound
numbers on glycan microarray for DG calculation)
Kd (nM) (at 25°C)
EH297 EH349 EH485 EH12 K514
E. coli strain
D-mannose NB 2620 3030 2700 2830
Mana-triethylene glycol (6) ND ND 27
Mana1-2Man 1460 ND 1260
Mana1-3Man 196 338 320
Mana1-4Man ND ND 1800
Mana1-6Man ND 2190 1880
Mana1-2Mana1-2Mana-triethylene glycol (4) ND ND 587
Mana1-6Mana1-6Mana-triethylene glycol (7) ND ND 756
Branched mannosides EH485 EH12 K514
Mannotriose (3)
Man 6
3
Manα1
Manα1
Manα1
Manα1
Manβ1-4GlcNAcβ1-4GlcNAc
Manβ1-4GlcNAcβ1-4GlcNAc
Manβ1-4GlcNAcβ1-4GlcNAc
Manβ1-4GlcNAcβ1-4GlcNAc
Manβ1-4GlcNAcβ1-4GlcNAc
Manβ1-4GlcNAcβ1-4GlcNAc
Manβ1-4GlcNAcβ1-4GlcNAc
6
3
Man 6
3
Manα1
Manα1
6
3
Manα1
Manα1
Manα1
Manα1
6
3
Manα1
Manα1 6
3
6
3
Manα1
Manα1 Manα1
6
3
2
2
Manα1
Manα1
6
3
Manα1
6
3
Manα1
Manα1
Manα1-2Manα1
Manα1
6
3
2
Manα1
Manα1-2Manα1
Manα1M anα1
6
3
Manα1
6
3
2
Manα1
Manα1-2Manα1
6
3
Manα1-2Manα1M anα1
Manα1
6
3
2
6
3
Manα1-2Manα1
Manα1-2Manα1
Manα1-2Manα1M anα1
Manα1
ND 307 204
Oligomannose 3 ND 20 18
Mannopentaose ND 110 127
Oligomannose 5 ND 20 12
Oligomannose 6 (2) ND ND 229
Oligomannose 7D1 ND ND 332
Oligomannose 7D3 ND 208 224
Oligomannose 8D1D3 ND ND 140
Oligomannose 9 (1) 419 ND 426
NB, no binding; ND, not determined.
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haemagglutination
To gain insight into the basis of differential bacterial adhe-
sion caused by FimH variation, we compared the
haemagglutination titres of the isogenic strains, comple-
mented with recombinant variant or mutant FimH, and we
also measured the haemagglutination of the wild-type
isolates (Table 3). An isogenic, ﬁmH-negative strain was
complemented with recombinant ﬁmH variants and
mutants. No large differences were observed in haemag-
glutination titres between the ﬁmH-complemented
isogenic strains, except for ﬁmHEH297 that was negative.
The recombinant strain carrying the single Ser78Asn
mutation in FimH gives the same agglutination titre as
those with ﬁmHK514 (K-12 E. coli) and ﬁmHJ96 (UPEC). The
isogenic strains producing FimH mutants Asn70Ser and
Asn70Ser/Ser78Asn agglutinated twofold less. The inter-
est for these mutations comes from the frequent occur-
rence of the double FimH mutant Asn70Ser/Ser78Asn, as
in the EH12, F-18 and CI#4 strains of our study (Fig. 3).
The recombinant strains expressing variants ﬁmHEH12,
ﬁmHEH349 and ﬁmHEH485 led to twofold, two- to fourfold and
four- to eightfold less haemagglutination respectively. The
wild-type O157:H7 isolates EH349, EH297 and EH485
did not haemagglutinate at all, whereas the non-O157
EH12 isolate and K514 agglutinate to the same titre as the
isogenic strain carrying ﬁmHJ96. In summary, the original
strains, corresponding to those ﬁmH variants that perform
least in their recombinant form in the isogenic strain, fail to
haemagglutinate (Table 3).
The Asn135Lys mutation renders O157:H7 FimH
inactive
Another important observation is that FimHrbEH297 does
not bind any mannosides (Table 2). EH297 is an O157:H7
isolate that carries the Asn135Lys mutation in the
mannose-binding pocket. FimHrbEH297 does not recognize
the monoclonal antibody 1C10 Fab that is used in the
SPR binding assay. This is consistent with 1C10 being
competitive with mannose for binding of the FimH
mannose-binding pocket. Moreover, neither the wild-type
EH297 isolate, nor the isogenic strain that has been
complemented with full-length FimHEH297, haemaggluti-
nate red blood cells. These data give for the ﬁrst time
proof that the Asn135Lys mutation renders FimH inactive
for mannose-receptor binding. Among the 22 new
sequences of ﬁmH from EHEC strains (Fig. S3), all non-
O157 strains carry FimH with an asparagine at position
135. On the other hand, only ﬁve of 11 O157 strains carry
FimH with a functional mannose-binding pocket. Non-
O157 EHEC as well as some O157 could thus be impli-
cated in non-diarrhoeal haemolytic uraemic syndrome
(HUS) associated with UTIs (Starr et al., 1998; Hogan
et al., 2001).
Discussion
A large body of data on FimH-mediated adhesion has
accumulated over the years from studies investigating the
binding of whole piliated bacteria to yeast cells, yeast
mannan, red blood cells, ﬁbronectin and derived peptides
(Sokurenko et al., 1994; 1995), collagen (Pouttu et al.,
1999), urothelial or bladder and buccal or gut cell lines
(Sokurenko et al., 1998; Duncan et al., 2005). Whereas
such studies are useful for understanding bacterial adhe-
sion at a cellular level, the availability of soluble FimH
truncates containing the receptor-binding domain allowed
us to characterize FimH receptor recognition at the
molecular level. The ratios of the affinities of FimH that we
measured in the current study for different oligomanno-
sides correlate remarkably well with the ratios of oligom-
annoside concentrations needed for 50% inhibition of
bacterial adhesion (Firon et al., 1982; 1984). A link
between cellular and molecular FimH-receptor binding
can thus be established.
Mannose binds to all FimH variants examined with a
dissociation constant in the micromolar range (Tables 1
and 2), corresponding to unusually tight lectin binding of a
monosaccharide. The high affinity is explained by the
structures of the FimH receptor-binding domain in
complex with mannose, which reveals a deep binding
pocket that almost completely buries the sugar and inter-
acts strongly with all of its hydroxyl groups except for the
anomeric one (Hung et al., 2002; Bouckaert et al., 2005).
All mannosides tested in the high-mannose microarray
experiment bound to FimH and gave rise to alike ﬂuores-
cence signals (Figs. 2 and S2), with the single exception
of D-mannose, which bound signiﬁcantly better. The
strong signal for FimH binding to D-mannose on the array
is in agreement with the enhanced affinity of a-D-mannose
triethylene glycol over D-mannose as measured by SPR
(Table 2). The direct linkage of mannose to triethylene
glycol (Fig. 2, insert) at the reducing end of mannose
Table 3. Haemagglutination titres of E. coli expressing ﬁmH alleles.
ﬁmH Pathotype Isolates Recombinant
J96 UPEC 1 1
K514 K-12 1 1
EH12 EHEC 1 1/2
EH349 EHEC 0 1/2–1/4
EH485 EHEC 0 1/4–1/8
EH297 EHEC 0 0
S78N Mutant NA 1
N70S Mutant NA 1/2
N70S, S78N Mutant NA 1/2
NA, not applicable.
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for FimH, through interactions with the tyrosine gate,
similar to what has been found for aliphatic linkers on
mannose (Bouckaert et al., 2005). Di- and oligomanno-
sides do not undergo a similar enhancement in affinity, as
the distance between the FimH-binding non-reducing
mannose and the linker becomes too large. The resulting
high ﬂuorescence signals should be considered an arte-
fact if one only takes the attached carbohydrate into con-
sideration; however, they represent true signals that
reﬂect the recognition of the mannose inclusive its linker.
This demonstrates the potential impact of linkers on
(mono)saccharides used to attach the carbohydrate to
microarrays or sensor chips and also shows that large
differences in binding strength can be distinguished using
microarrays. Hence we are particularly encouraged by the
potential of the carbohydrate microarray technology for
high-throughput screening of inhibitors to prevent FimH–
mannose interactions. Compound 3, or mannotriose,
does not give an outstanding signal for FimH binding on
the microarray. It differs from oligomannose 3 by the lack
of a chitobiose core (GlcNAc)2 (Table 2). Presence of the
chitobiose unit is expected to elevate the ﬂuorescent
signal towards a level similar as for a-D-mannose trieth-
ylene glycol (Fig. 4 and Table 2). Comparison with DG
values (Fig. 2) clariﬁes that whereas a distinction can be
made for large differences in affinity using the glycan
microarray, quantiﬁcation of the results for closely related
affinities is difficult.
Type-1 ﬁmbriated bacteria from different E. coli clinical
isolates have altered mannoside binding and adhesion
proﬁles. Recombinant E. coli expressing a CI#4 (UPEC)
FimH variant adhere tightly to yeast mannan, A498
human kidney cells, and J82 human bladder cells,
whereas bacteria expressing FimH from the faecal E. coli
F-18 strain show poor adhesion to all three substrates
(Sokurenko et al., 1997). Minor sequence variations in
FimH have been held responsible for these differences
(Sokurenko et al., 1994; 1995; 1997; 1998). However, we
do not observe a correlation between FimH variation and
the affinities or speciﬁcities of the variant FimH receptor-
binding domains for oligomannosides (Tables 1 and 2).As
an example, our data show that there are no signiﬁcant
differences between faecal FimHrbF-18 and UPEC
FimHrbCI#4 in their affinities for D-mannose or trimannoside
(Table 1). Hence, the single Gly73Glu amino acid differ-
ence between these two FimH variants does not directly
impact affinity. This suggests that factors other than dif-
ferences in mannose binding of FimH per se cause the
different adhesion phenotypes.
Many of the variable residues of FimH are located near
the base of the receptor-binding domain (Fig. 3B), in the
vicinity of the ﬂexible linker connecting the receptor-
binding and pilin domains in FimH. Based on computer
simulations, it has been suggested that minor sequence
differences in or near the linker region might affect the
ease with which the receptor-binding domain can undergo
conformational changes upon bacterial adhesion, as
these changes propagate from the linker strand to the
mannose-binding site (Thomas et al., 2002). Nonethe-
less, FimH receptor-binding domains rarely exceed 1%
difference in identity and the FimH pilin domain is even
more conserved. FimA sequences display larger differ-
ences in identity (91–99%) than FimH (Vandemaele et al.,
2003). It was already suggested early on that the ﬁmbrial
shaft, which is almost exclusively built from FimA,
imposes the presentation of the FimH adhesin on the
bacterial surface (Firon et al., 1983). The ﬁmbrial shaft
has recently been shown as an important determinant in
the sugar ﬁne speciﬁcity of bacterial adhesion phenotypes
(Madison et al., 1994; Duncan et al., 2005). In conclusion,
differences between FimH variants, with the exception of
those carrying theAsn135Lys mutation, are observed only
when FimH is expressed in the context of its ﬁmbrial shaft,
whereas in its soluble form the FimH receptor-binding
domains exhibits the same tissue tropism.
The number of ﬁmbriae per cell and the number of
ﬁmbriated cells could of course also inﬂuence bacterial
adhesion. The limited information to date indicate that
these numbers are rather constant (McCormick et al.,
1989); however, it may be difficult to determine numbers
of ﬁmbriae with the accuracy required to interpret the
relatively small differences in the number of adherent
bacteria between strains. The multivalent nature of the
bacterium–substratum interaction would further blur
small differences in ﬁmbrial numbers, by enhancing its
effects on bacterial adhesion in a non-linear manner. In
our haemagglutination study, expression of recombinant
ﬁmHEH12, ﬁmHEH349 or ﬁmHEH485 in an isogenic strain have
a twofold, two- to fourfold and four- to eightfold lower
haemagglutination titres compared with recombinant
ﬁmHJ96 in the same isogenic strain. This degree of dif-
ferentiation agrees well with the reported 2–12-fold dif-
ferences in number of adherent bacteria for isogenic
strains expressing ﬁmH alleles (Sokurenko et al., 1995;
1997). Remarkably, O157:H7 EHEC isolates EH349 and
EH485 do not agglutinate rabbit red blood cells and are
the parent strains for those FimH variants that haemag-
glutinate least optimal when expressed in their recombi-
nant form in the isogenic strain (Table 3). Taking into
account that all variant receptor-binding domains display
similar affinities (Tables 1 and 2; Fig. 4), with the excep-
tion of the non-binding FimHEH297 variant, FimH variation
could possibly affect pilus assembly. The tip adhesin is
indeed crucial to initiate pilus assembly by interactions
between the FimH receptor-binding domain and the
usher outer membrane export channel (Barnhart et al.,
2003).
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(Fig. 4), suggesting their binding sites are structurally
highly conserved. The differential binding of the individual
oligomannoses presumably depends on how well the car-
bohydrate ﬁts into the tyrosine gate (Bouckaert et al.,
2005). Both Mana1-3Man and the linear trisaccharide,
Mana1-3Mana1-6ManaOMe, bind about 10-fold tighter
than D-mannose (Tables 1 and 2). The branched carbo-
hydrates mannotriose and mannopentaose do not bind
signiﬁcantly better than their linear moieties. Instead they
bind comparably to Mana1-3Man, making the existence
of a second binding site or subsite on FimH unlikely.
Affinity for FimH is enhanced by another factor of 10
through b1-4 linkage of the non-reducing Mana1-3Man to
the GlcNAc residue in the chitobiose core of
N-glycosylated proteins. The b-linkage of mannotriose
alone does not lead to outstanding ﬂuorescence signals
on the microarray (compound 5 in Figs 2, S1 and S2), to
match the high affinity of oligomannose 3 with that of
triethylene glycol-linked a-D-mannose (Table 2), but
rather behaves like oligomannoses 6 and 9. This suggests
that GlcNAc in itself, rather than the anomeric state of the
glycosidic linkage, accounts for enhanced binding. Our
docking studies predict that enhanced binding of Mana1-
3Manb1-4GlcNAc is accomplished by interactions of the
central mannose and GlcNAc in the tyrosine gate (Fig. 5).
In those oligomannosides (oligomannoses 3 and 5)
where the D1 arm, Mana1-3Manb1-4GlcNAc, is not ham-
pered at the non-reducing end by an a1-2 linked mannose
residue (Rosenstein et al., 1988), the affinity is very high
(around 20 nM, Table 2), paralleling the affinity of FimH
for aryl and alkyl mannosides (Bouckaert et al., 2005).
Oligomannoses with a substituted D1 arm but with a free
D2 arm (oligomannoses 6, 7D1, 7D3 and 8D1D3) reach
affinities comparable to those for Mana1-3Man, indicating
that FimH largely targets the D2 arm in those cases. The
D2 arm is further substituted with an a1-2 linked mannose
residue in oligomannose 9. The largest oligomannose is
therefore not the best binder. Nevertheless, both the
length and the multivalency of the oligomannoses make a
minor contribution to affinity. Oligomannose 9 beneﬁts
over Mana1-2Man from the enhanced probability to
encounter an a1-2 linked mannose. Mannopentaose ben-
eﬁts over mannotriose from the twofold presence of ter-
minal Mana1-3Man. Finally, Mana1-2Mana1-2Man has a
larger affinity than Mana1-2Man and Mana1-6Mana1-
6Man than Mana1-6Man. The extended length of these
glycans may increase the number of interactions of these
glycans with the tyrosine gate of FimH.
Our results show that a free, non-reducing Mana1-
3Manb1-4GlcNAc on the D1 branch of high-mannose
glycans is a 100-fold stronger FimH epitope than a-D-
mannose. This trisaccharide, isolated as the main com-
ponent in the urine from mannosidosis patients (Norden
et al., 1973), has previously been found to be the best
inhibitor of red blood cell agglutination and yeast aggre-
gation studies in the early work of the group of Sharon
(Firon et al., 1982; 1983; 1984). Interestingly, UTIs are not
described as one of the burdens of mannosidosis
patients. The origin of this trisaccharide is not known, but
could be Tamm-Horsfall protein [THP, uromodulin;
reviewed in the study by Devuyst et al. (2005)]. THP is a
heavily glycosylated GPI-anchored protein located on the
cells lining the thick ascending limb of Henle’s loop in the
kidney. A speciﬁc protease cleaves THP and releases
large amounts into the urine (~50 mg day-1 in urine from
healthy human individuals), making it the most abundant
protein in normal human urine. THP provides a ﬁrst line of
defence against UTIs (Pak et al., 2001). THP knockout
mice have been shown to be more prone to bladder
infection by type-1 ﬁmbriated UPEC (Bates et al., 2004;
Mo et al., 2004). There are seven N-glycosylation sites in
THP, of which one, Asn251, carries high-mannose carbo-
hydrate chains (van Rooijen et al., 1999). In humans, the
most abundant glycoform is Man6 (75%), followed by
Man7 (17%) and Man5 (8%) (Cavallone et al., 2004).
Man5 is the only one of these glycoforms that exposes
Mana1-3Manb1-4GlcNAc at the non-reducing end of its
high-mannose D1 arm (Table 2). In pigs, the most abun-
dant glycoform is also Man6 (53%), but the Man5 content
is much higher (47%) than in human THP. Pig THP binds
about threefold better than human THP to type-1 ﬁmbri-
ated E. coli (Cavallone et al., 2004), consistent with our
ﬁnding that glycan structures exposing the Mana1-
3Manb1-4GlcNAc epitope provide the tightest FimH
binding.
The physiological receptor for FimH in the urinary tract
is UPIa (Wu et al., 1996; Zhou et al., 2001). The glycosy-
lation pattern of human UPIa is not known, but the mouse
protein presents very low amounts of oligomannose 6,
and similar amounts of oligomannose 7, 8 and 9 (Xie
et al., 2006). Of those, only oligomannoses 6 and 7D1
carry a free, non-reducing mannotriose (see Table 2). This
is congruent with our previous ﬁnding that interactions of
FimH with mannose, and not with mannotriose, are rel-
evant in the human urinary tract, despite the 10-fold
higher affinity of FimH for mannotriose (Hung et al., 2002).
The highest-affinity epitope for FimH, Mana1-3Manb1-
4GlcNAc, is not free for binding to FimH in any of the
recently elucidated glycan structures on mouse UPIa (Xie
et al., 2006). However, a change in the glycosylation of
UPIa or other urothelial surface proteins may alter the
host susceptibility to UTIs (Xie et al., 2006). There is
ample evidence that the carbohydrate expression proﬁle
of eukaryotic cells can be subject to variation [for a review,
see the study by Durand and Seta (2000)] in certain
disease states, but also under normal physiological con-
ditions such as menopause and ageing. Interestingly in
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healthy individuals (Hoepelman et al., 2003). Type-1-
ﬁmbriated E. coli adhere twice as many to urothelial cells
of diabetic patients than of healthy individuals, indepen-
dently from the presence of various substances excreted
in the urine, such as albumin, glucose and THP (Geerlings
et al., 2002). Unfortunately, it is currently unknown
whether this can be attributed to altered glycosylation of
FimH receptors in the urinary tract.Abetter understanding
of the fundamental relationships between physiological
conditions of the host and carbohydrate expression on
urothelial cells is thus needed.
The differences in affinities of FimH for mannose struc-
tures are an order of magnitude larger than previously
reported differences in bacterial adhesion. Affinities of
FimH for high-mannose substructures differ 100-fold
(Table 2), while reported differences in bacterial adhesion
are 2–12-fold (Sokurenko et al., 1995; 1997). This implies
that the carbohydrate expression proﬁle of the targeted
host tissues and of protective molecules such as THP
could be more important determinants of FimH-mediated
bacterial adhesion. Adhesion differences may thus be
receptor- rather than adhesin-based. In summary, we
determined the speciﬁcities of the type-1 adhesin FimH
for its high-mannose receptors and demonstrated the
conservation of these speciﬁcities in UPEC strains
expressing variant FimH adhesins. The conserved nature
of FimH carbohydrate recognition suggests that tight-
binding FimH ligands will have broad range efficiency in
preventing type-1 pilus-mediated adhesion and bacterial
infection.
Experimental procedures
Preparation of FimH receptor-binding (rb) domains
FimHrbJ96 was expressed from plasmid pPKL241, FimHrbCI#4
from plasmid pMAS146 and FimHrbF-18 from plasmid
pPKL316 in HB101 (Schembri et al., 2000). We selected four
variants after sequencing of ﬁmH from 22 EHEC strains (Fig.
S3) to represent the variation in EHEC FimH. EH12
(O2:K1:H6), EH297 (O157:H7) and EH349 (O157:H7) are
human clinical isolates, EH485 (O157:H7) was isolated from
a bovine carcass. Constructs for FimHrbK514, FimHrbEH12, Fim-
HrbEH297, FimHrbEH349 and FimHrbEH485 were prepared using
the Gateway vector pDEST14 and transformed into E. coli
C43 (DE3). In all cases, the ﬁmH genes were truncated after
Thr158, followed by a 6-histidine tag. The same expression
and puriﬁcation protocol was used for all variants as for
FimHrbJ96 (Bouckaert et al., 2005).
Haemagglutination experiments
The effect of FimH variation and mutation on bacterial adher-
ence was evaluated by means of rabbit red blood cell agglu-
tination on ice, both by using the clinical isolates and wild-
type strains. Full-length ﬁmH genes from natural variants
(K514, EH12, EH297, EH349 and EH485 isolates) were
cloned into pDONR221 (Gateway). Mutations (N70S, S78N,
N70S/S78N) were introduced in the clone pENT53, carrying
the full-length ﬁmH gene from strain K514. The mutations
were designed to simulate the effect of variations between
uropathogenic and faecal E. coli strains. Transformation into
the AAEC185(pUT2002) strain (Minion et al., 1989) comple-
ments the pUT2002 plasmid, encoding for the whole ﬁm
operon except for ﬁmH. Bacteria were grown statically for
24–48 h at 37°C in Luria Broth (LB), to reach optimal ﬁmbrial
expression. Bacteria were pelleted by centrifugation, washed
three times in phosphate buffered saline (PBS) and diluted to
an equal dispersity at 600 nm. To a twofold dilution series of
the bacteria in round-well microtitre plates, 50 ml of 4% fresh
rabbit red blood cells were added. Haemagglutination was
read out as positive when the red blood cells did not precipi-
tate in the circular centre of the well, but instead remained
homogeneously dispersed in the solution through ﬁmbrial
interactions with the bacteria.
Affinity measurements
High-mannose microarray. The high-mannose microarray
was prepared as described (Fig. S1 and Adams et al., 2004).
For hybridization experiments, FimHrbJ96 (10 mg) was added
to a solution containing 10 mM HEPES, 10 mM MES,
150 mM NaCl, 0.5 mM CaCl2 and 0.05% Triton X-100 (pH
7.4). In this study, 80–90 ml of the protein solution was placed
on the slide and distributed over the surface of the slide by
using hybridization coverslips (HybriSlip, Molecular Probes).
After 2 h at room temperature, the slides were washed twice
with incubation buffer, twice with distilled water, and then
centrifuged for 5 min to ensure dryness. For detection of
bound FimH, arrays were incubated with Penta-His Alexa
Fluor 555 monoclonal antibody (2 mg in 80–90 ml of incuba-
tion buffer; Qiagen AG) for 1 h and then washed and dried as
described earlier. Microarrays were scanned by using a stan-
dard ﬂuorescence slide scanner (LS400 Tecan). The spots
were quantiﬁed by using Scan Array Express Software
(Perkin Elmer).
Binding of linear trimannosides via the displacement of [
3H]
D-mannose. [
3H] D-mannose was obtained from Amersham.
Linear trimannosides were synthesized and dissolved in
double distilled water to give stock solutions of 0.87 M
Mana1-2Mana1-2ManaOMe, 0.25 M Mana1-2Mana1-
3ManaOMe, 0.27 M Mana1-2Mana1-6ManaOMe, 0.30 M
Mana1-3Mana1-6ManaOMe and 0.13 M Mana1-6Mana1-
6ManaOMe. The binding experiments were performed in
duplicate and as described previously (Bouckaert et al.,
2005).
Competition experiments using SPR. We used Fab frag-
ments of the monoclonal antibody 1C10, recognizing the
mannose-binding site of FimH, to determine the solution affin-
ity of FimH–carbohydrate interactions. The monoclonal anti-
body 1C10 was produced by a mouse hybridoma cell line at
Medimmune and its Fab fragments were prepared and
puriﬁed. All oligosaccharides were purchased from Dextra
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on a Biacore3000™ as described previously (Bouckaert
et al., 2005). Brieﬂy, Fabs of the monoclonal antibody 1C10
were immobilized via amine coupling at 1000 Resonance
Units (1000 pg ligand mm
-2) on a CM5 sensor chip (BIAap-
plications Handbook, Biacore AB, Uppsala, Sweden). The
kinetic constants for binding of FimH to the immobilized anti-
body were ﬁrst determined, using different concentrations of
FimH in phosphate buffered saline with 0.005% surfactant
P20 and 3 mM EDTA, at a ﬂow rate of 20 ml min
-1 and at
298 K. A Langmuir binding isotherm with a 1:1 stoichiometry
was ﬁtted to the data to obtain ka and kd and the maximal
binding Rmax. Secondly, the equilibrium dissociation constants
Kd of FimH–saccharide interactions were determined in a
competition experiment. Samples containing a ﬁxed concen-
tration of FimH (close to the calculated Kd of the FimH–
antibody interaction) were used in combination with a
concentration range of the sugar. A Langmuir binding iso-
therm with a 1:1 stoichiometry was ﬁtted to the data, while
keeping ka and kd and Rmax from the foregoing experiment
constant, to obtain the concentrations of bound FimH. Every
measurement was repeated at least twice, most often includ-
ing different protein and sugar batches.
Computational docking
Computational docking of trimannosides to FimH was carried
out using AutoDock3 (Morris et al., 1998). Because the
protein is represented by a grid of affinity potentials in
AutoDock3, the protein conformation is ﬁxed during the
docking procedure. Flexibility of ligands is accounted for by
allowing rotation around ﬂexible torsion angles. The docked
energies are calculated as the sum of the intermolecular
interaction energy and the internal energy of the ligand. The
search for the best interaction energy was carried out by
means of the Lamarckian genetic algorithm. Ligand struc-
tures were obtained from the PDB-database and prepared for
docking by adding hydrogens and charges with AutoDock-
Tools (Sanner et al., 1996). Each simulation consisted of 100
independent runs, with a population size of 100, 50 000 gen-
erations, and a maximum of 5 000 000 energy evaluations.
The large parameter values used here were required to
achieve convergence when docking the big and ﬂexible
trisaccharide ligands. Solutions were ranked based on their
docking energies, and similar solutions were clustered
(cluster cut-off r.m.s.d.  1 Å). The top solutions were visu-
ally inspected using O (Jones et al., 1991).
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